Juno Therapeutics, Inc. - FORM S-1 - EX-23.1 - CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - November 17, 2014

Attached files

file filename
S-1 - FORM S-1 - Juno Therapeutics, Inc.d772541ds1.htm
EX-10.12(A) - EXCLUSIVE LICENSE AGREEMENT, SEATTLE CHILDREN'S HOSPITAL - Juno Therapeutics, Inc.d772541dex1012a.htm
EX-10.1 - EXCLUSIVE LICENSE AGREEMENT - Juno Therapeutics, Inc.d772541dex101.htm
EX-10.20 - FORM OF RESTRICTED STOCK AGREEMENT UNDER THE 2013 EQUITY INCENTIVE PLAN - Juno Therapeutics, Inc.d772541dex1020.htm
EX-10.8 - MASTER SPONSORED RESEARCH AGREEMENT - Juno Therapeutics, Inc.d772541dex108.htm
EX-10.16 - OFFER LETTER AGREEMENT, MARK FROHLICH, M.D. - Juno Therapeutics, Inc.d772541dex1016.htm
EX-10.14 - OFFER LETTER AGREEMENT, HANS E. BISHOP - Juno Therapeutics, Inc.d772541dex1014.htm
EX-10.9 - MASTER CLINICAL STUDY AGREEMENT, MEMORIAL SLOAN-KETTERING CANCER CENTER - Juno Therapeutics, Inc.d772541dex109.htm
EX-10.12(B) - AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AGREEMENT - Juno Therapeutics, Inc.d772541dex1012b.htm
EX-10.21 - FORM OF STOCK OPTION GRANT NOTICE & OPTION AGREEMENT UNDER 2013 EQUITY INC PLAN - Juno Therapeutics, Inc.d772541dex1021.htm
EX-10.15 - OFFER LETTER AGREEMENT, BERNARD J. CASSIDY - Juno Therapeutics, Inc.d772541dex1015.htm
EX-10.10 - LETTER AGREEMENT, MEMORIAL SLOAN KETTERING CANCER CENTER - Juno Therapeutics, Inc.d772541dex1010.htm
EX-4.1 - AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT - Juno Therapeutics, Inc.d772541dex41.htm
EX-10.26 - SUBLEASE AGREEMENT, SEATTLE BIOMEDICAL RESEARCH INSTITUTE - Juno Therapeutics, Inc.d772541dex1026.htm
EX-10.7(A) - EXCLUSIVE LICENSE AGREEMENT, MEMORIAL SLOAN-KETTERING CANCER CENTER - Juno Therapeutics, Inc.d772541dex107a.htm
EX-10.18 - FORM OF DIRECTOR AND EXECUTIVE OFFICER INDEMNIFICATION AGREEMENT - Juno Therapeutics, Inc.d772541dex1018.htm
EX-10.7(B) - AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AGREEMENT, MEMORIAL SLOAN KETTERING CANCER - Juno Therapeutics, Inc.d772541dex107b.htm
EX-10.17 - OFFER LETTER AGREEMENT, STEVEN D. HARR, M.D. - Juno Therapeutics, Inc.d772541dex1017.htm
EX-10.11 - EXCLUSIVE LICENSE AGREEMENT, ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. - Juno Therapeutics, Inc.d772541dex1011.htm
EX-10.5 - LETTER AGREEMENT, FRED HUTCHINSON CANCER RESEARCH CENTER - Juno Therapeutics, Inc.d772541dex105.htm
EX-10.19 - 2013 EQUITY INCENTIVE PLAN, AS AMENDED - Juno Therapeutics, Inc.d772541dex1019.htm
EX-10.13 - SPONSORED RESEARCH AGREEMENT, SEATTLE CHILDREN'S HOSPITAL - Juno Therapeutics, Inc.d772541dex1013.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated September 12, 2014, in the Registration Statement (Form S-1) and related Prospectus of Juno Therapeutics, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Seattle, Washington

November 14, 2014

Juno Therapeutics, Inc. Reports